Pharmacoenhancement of low crizotinib plasma concentrations in patients with anaplastic lymphoma kinase-positive non-small cell lung cancer using the CYP3A inhibitor cobicistat - Hohmann, Nicolas; Bozorgmehr, Farastuk; Christopoulos, Petros; Mikus, Gerd; Blank, Antje; Burhenne, Jürgen; Thomas, Michael; Haefeli, Walter E. (Clinical and translational science, 2021)
First published: 22 November 2020